carbamazepine has been researched along with Acute Onset Vascular Dementia in 4 studies
Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the efficacy of oxcarbazepine (OXC) in the treatment of agitation and aggression in patients with Alzheimer's disease, vascular dementia or both." | 9.14 | Effect of oxcarbazepine in the treatment of agitation and aggression in severe dementia. ( Aga, O; Cvancarova, M; Engedal, K; Olsen, IC; Selbaek, G; Sommer, OH, 2009) |
| "The efficacy, safety, and tolerability of carbamazepine in the treatment of agitation and aggression associated with dementia were assessed." | 9.08 | Efficacy and tolerability of carbamazepine for agitation and aggression in dementia. ( Cox, C; Erb, R; Irvine, C; Jakimovich, L; Patel, S; Podgorski, CA; Tariot, PN, 1998) |
| "To evaluate the efficacy of oxcarbazepine (OXC) in the treatment of agitation and aggression in patients with Alzheimer's disease, vascular dementia or both." | 5.14 | Effect of oxcarbazepine in the treatment of agitation and aggression in severe dementia. ( Aga, O; Cvancarova, M; Engedal, K; Olsen, IC; Selbaek, G; Sommer, OH, 2009) |
| "The efficacy, safety, and tolerability of carbamazepine in the treatment of agitation and aggression associated with dementia were assessed." | 5.08 | Efficacy and tolerability of carbamazepine for agitation and aggression in dementia. ( Cox, C; Erb, R; Irvine, C; Jakimovich, L; Patel, S; Podgorski, CA; Tariot, PN, 1998) |
| "Hashimoto encephalopathy is a chronic relapsing steroid responsive encephalopathy characterized by antibodies against thyroid components." | 1.32 | [Hashimoto encephalopathy]. ( Günther, P; Kopf, A, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sommer, OH | 1 |
| Aga, O | 1 |
| Cvancarova, M | 1 |
| Olsen, IC | 1 |
| Selbaek, G | 1 |
| Engedal, K | 1 |
| Duggal, HS | 1 |
| Singh, I | 1 |
| Günther, P | 1 |
| Kopf, A | 1 |
| Tariot, PN | 1 |
| Erb, R | 1 |
| Podgorski, CA | 1 |
| Cox, C | 1 |
| Patel, S | 1 |
| Jakimovich, L | 1 |
| Irvine, C | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Effect of Oxcarbazepine in the Treatment of Agitation / Aggression in Dementia (OBAD) - An Eight Week Prospective, Randomized, Double-Blind, Placebo-Controlled, Multi Center Trial. A Phase III Study[NCT00145691] | Phase 3 | 100 participants | Interventional | 2005-09-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for carbamazepine and Acute Onset Vascular Dementia
| Article | Year |
|---|---|
Effect of oxcarbazepine in the treatment of agitation and aggression in severe dementia.
Topics: Aged; Aged, 80 and over; Aggression; Alzheimer Disease; Anticonvulsants; Carbamazepine; Dementia; De | 2009 |
Efficacy and tolerability of carbamazepine for agitation and aggression in dementia.
Topics: Aged; Aged, 80 and over; Aggression; Alzheimer Disease; Carbamazepine; Dementia; Dementia, Vascular; | 1998 |
2 other studies available for carbamazepine and Acute Onset Vascular Dementia
| Article | Year |
|---|---|
New-onset vascular mania in a patient with chronic depression.
Topics: Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Dementia, Vascular; Depress | 2009 |
[Hashimoto encephalopathy].
Topics: Aged; Anticonvulsants; Brain Diseases; Carbamazepine; Dementia, Vascular; Diagnosis, Differential; D | 2004 |